Abstract:N-glycosylation can affect the host specificity, virulence and infectivity of influenza A viruses (IAVs). In this study, the distribution and evolution of N-glycosylation sites in the hemagglutinin (HA) and neuraminidase (NA) of H9N2 virus were explored using phylogenetic analysis. Then, one strain of the H9N2 subtypes was proliferated in the embryonated chicken eggs (ECE) and human embryonic lung fibroblast cells (MRC-5) system. The proliferated viral N-glycan profiles were analyzed by a glycomic method that combined the lectin microarray and MALDI-TOF/TOF-MS. As a result, HA and NA of H9N2 viruses prossess six and five highly conserved N-glycosylation sites, respectively. Sixteen lectins (e.g., MAL-II, SNA and UEA-I) had increased expression levels of the glycan structures in the MRC-5 compared with the ECE system; however, 6 lectins (e.g., PHA-E, PSA and DSA) had contrasting results. Eleven glycans from the ECE system and 13 glycans from the MRC-5 system were identified. Our results showed that the Fucα-1,6GlcNAc(core fucose) structure was increased, and pentaantennary N-glycans were only observed in the ECE system. The SAα2-3/6Gal structures were highly expressed and Fucα1-2Galβ1-4GlcNAc structures were only observed in the MRC-5 system. We conclude that the existing SAα2-3/6Gal sialoglycans make the offspring of the H9N2 virus prefer entially attach to each other, which decreases the virulence. Alterations in the glycosylation sites for the evolution and role of IAVs have been widely described; however, little is known about the exact glycan structures for the same influenza strain from different hosts. Our findings may provide a novel way for further discussing the molecular mechanism of the viral transmission and virulence associated with viral glycosylation in avian and human hosts as well as vital information for designing a vaccine against influenza and other human viruses.

The Effect and Function of Glycosylation for Influenza Virus

Multivalent Interactions Between Fully Glycosylated Influenza Virus Hemagglutinins Mediated by Glycans at Distinct N-glycosylation Sites

New Progress of Glycan As Receptors for Influenza Virus

Glycosylation of viral proteins: Implication in virus–host interaction and virulence

Influence of Host Sialic Acid Receptors Structure on the Host Specificity of Influenza Viruses

Relevance of Host Cell Surface Glycan Structure for Cell Specificity of Influenza A Viruses

N-glycan Profiles in H9N2 Avian Influenza Viruses from Chicken Eggs and Human Embryonic Lung Fibroblast Cells.

Glycosylation Site Alteration in the Evolution of Influenza A (H1N1) Viruses.

Prediction of Biological Functions on Glycosylation Site Migrations in Human Influenza H1N1 Viruses.

Glycosylation Modification and Related Functions of Virus and Host Cells

Intact Glycopeptide Analysis of Influenza A/H1N1/09 Neuraminidase Revealing the Effects of Host and Glycosite Location on Site‐Specific Glycan Structures

Complexities of Interactions Between Influenza Virus and Its Receptors

[Role of Glycoconjugates and Mammalian Sialidases Involved in Viral Infection and Neural Function]

The Mechanism of Glycosylation in SARS-CoV-2 Infection and Application in Drug Development

Mapping and Functional Analysis of S1 Subunit Glycosylation of Avian Infectious Bronchitis Virus

The Evolutionary Pattern of Glycosylation Sites in Influenza Virus (H5N1) Hemagglutinin and Neuraminidase

Exploitation of glycosylation in enveloped virus pathobiology

Effects of the Glycosylation of the HA Protein of H9N2 Subtype Avian Influenza Virus on the Pathogenicity in Mice and Antigenicity

Role of glycosylation in enveloped virus infection

Evolving Roles of Glycosylation in the Tug-of-war Between Virus and Host

Research of Anti-influenza Viral Activity of Glycoconjugates